Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients (pts) with advanced melanoma (MEL)

被引：3

作者：

Sznol, M. ^{[1
]}

Ferrucci, P. F. ^{[2
]}

Hogg, D. ^{[3
]}

Atkins, M. ^{[4
]}

Wolter, P. ^{[5
]}

Guidoboni, M. ^{[6
]}

Lebbe, C. ^{[7
]}

Kirkwood, J. ^{[8
]}

Schachter, J. ^{[9
]}

Daniels, G. ^{[10
]}

Hassel, J. ^{[11
]}

Cebon, J. ^{[12
]}

Gerritsen, W. ^{[13
]}

Atkinson, V. ^{[14
,15
]}

Thomas, L. ^{[16
]}

McCaffrey, J. ^{[17
]}

Power, D. ^{[18
]}

Jiang, J. ^{[19
]}

Hodi, F. S. ^{[20
]}

Wolchok, J. ^{[21
]}

机构：

[1] Yale Univ, Sch Med Med Oncol, Med Oncol, New Haven, CT USA

[2] Ist Europeo Oncol, Melanoma & Sarcoma, Milan, Italy

[3] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada

[4] Georgetown Univ, Hematol Oncol, Lombardi Canc Ctr, Washington, DC USA

[5] Univ Hosp Leuven, Dept Gen Med Oncol, Campus Gasthuisberg, Leuven, Belgium

[6] Ist Tumori Romagna IRST, Immunotherapy Unit, Meldola, Italy

[7] Hop St Louis, Dermatol, Paris, France

[8] Hillman Canc Ctr, Med Oncol & Hematol, Pittsburgh, PA USA

[9] Sheba Med Ctr, Ella Lemelbaum Inst Melanoma, Ramat Gan, Israel

[10] Moores UCSD Canc Ctr, Med, La Jolla, CA USA

[11] Univ Heidelberg Hosp, Oncol, Heidelberg, Germany

[12] Olivia Newton John Canc Res Inst, Canc Immunobiol, Heidelberg, Australia

[13] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Med Oncol, Nijmegen, Netherlands

[14] Gallipoli Med Res Fdn, Oncol, Greenslopes, Australia

[15] Princess Alexandra Hosp, Greenslopes, Australia

[16] Ctr Hosp Lyon Sud, Dermatol, Pierre Benite, France

[17] Irish Clin Oncol Res Grp, Med Oncol, Dublin, Ireland

[18] Irish Clin Oncol Res Grp, Med Oncol, Cork, Ireland

[19] BMS, Oncol, Princeton, NJ USA

[20] Dana Farber Canc Inst, Oncol, Boston, MA 02115 USA

[21] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw379.18

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1123P

引用

页数：1

共 50 条

[41] Nivolumab (NIVO) plus ipilimumab (IPI) plus cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040 [J].

Yau, Thomas ;

Zagonel, Vittorina ;

Santoro, Armando ;

Acosta-Rivera, Mirelis ;

Choo, Su Pin ;

Matilla, Ana ;

He, Aiwu Ruth ;

Gracian, Antonio Cubillo ;

El-Khoueiry, Anthony B. ;

Sangro, Bruno ;

Eldawy, Tarek ;

Bruix, Jordi ;

Frassineti, Giovanni ;

Vaccaro, Gina M. ;

Tschaika, Marina ;

Scheffold, Christian ;

Shen, Yun ;

Neely, Jaclyn ;

Piscaglia, Fabio .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)

[42] Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204. [J].

Tawbi, Hussein Abdul-Hassan ;

Forsyth, Peter A. J. ;

Algazi, Alain Patrick ;

Hamid, Omid ;

Hodi, F. Stephen ;

Moschos, Stergios J. ;

Khushalani, Nikhil I. ;

Gonzalez, Rene ;

Lao, Christopher D. ;

Postow, Michael Andrew ;

Atkins, Michael B. ;

Ernstoff, Marc S. ;

Puzanov, Igor ;

Kudchadkar, Ragini Reiney ;

Thomas, Reena Parada ;

Tarhini, Ahmad A. ;

Jiang, Joel ;

Avila, Alexandre ;

Demelo, Sheena ;

Margolin, Kim Allyson .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[43] Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) for patients with advanced melanoma (MEL) who progressed after prior ipilimumab (IPI) treatment [J].

Barros e Silva, Milton ;

Schmerling, Rafael ;

de Melo, Andreia Cristina ;

Azevedo, Sergio ;

Garicochea, Bernardo ;

McWhirter, Elaine ;

Smylie, Michael ;

Gifoni, Markus ;

dos Anjos, Carlos Henrique ;

Petrella, Teresa ;

Chacon, Matias ;

Greco, Martin ;

Nair, Suresh ;

Avila, Alexandre ;

Demelo, Sheena ;

Jiang, Joel ;

Ernst, Scott .

CANCER RESEARCH, 2017, 77

[44] Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915). [J].

Long, Georgina V. ;

Schadendorf, Dirk ;

Del Vecchio, Michele ;

Larkin, James ;

Atkinson, Victoria ;

Schenker, Michael ;

Pigozzo, Jacopo ;

Gogas, Helen J. ;

Dalle, Stephane ;

Meyer, Nicolas ;

Ascierto, Paolo A. ;

Sandhu, Shahneen ;

Eigentler, Thomas ;

Gutzmer, Ralf ;

Hassel, Jessica C. ;

Robert, Caroline ;

Carlino, Matteo ;

Di Giacomo, Anna Maria ;

Butler, Marcus O. ;

Munoz-Couselo, Eva ;

Brown, Michael P. ;

Rutkowski, Piotr ;

Haydon, Andrew ;

Grob, Jean-Jacques ;

Schachter, Jacob ;

Queirolo, Paola ;

Menzies, Alexander ;

Re, Sandra ;

Bas, Tuba O. ;

de Pril, Veerle ;

Tenney, Daniel ;

Tang, Hao ;

Weber, Jeffrey S. .

CANCER RESEARCH, 2021, 81 (13)

[45] Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040. [J].

El-Khoueiry, Anthony B. ;

Yau, Thomas ;

Kang, Yoon-Koo ;

Kim, Tae-You ;

Santoro, Armando ;

Sangro, Bruno ;

Melero, Ignacio ;

Kudo, Masatoshi ;

Hou Ming-Mo ;

Matilla, Ana ;

Tovoli, Francesco ;

Knox, Jennifer J. ;

He, Aiwu Ruth ;

El-Rayes, Bassel F. ;

Acosta-Rivera, Mirelis ;

Lim, Ho Yeong ;

Memaj, Arteid ;

Sama, Ashwin Reddy ;

Hsu, Chiun .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)

[46] Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067 [J].

Hodi, F. Stephen ;

Chiarion-Sileni, Vanna ;

Gonzalez, Rene ;

Grob, Jean-Jacques ;

Rutkowski, Piotr ;

Lao, Christopher D. ;

Cowey, Charles Lance ;

Schadendorf, Dirk ;

Wagstaff, John ;

Dummer, Reinhard ;

Queirolo, Paola ;

Smylie, Michael ;

Butler, Marcus O. ;

Hill, Andrew Graham ;

Marquez-Rodas, Ivan ;

Ritchings, Corey ;

Sakkal, Leon A. ;

Wang, Peter ;

Wolchok, Jedd D. ;

Larkin, James .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[47] UPDATED RESULTS FROM A PHASE 3 TRIAL OF NIVOLUMAB (NIVO) COMBINED WITH IPILIMUMAB (IPI) IN TREATMENT-NAIVE PATIENTS WITH ADVANCED MELANOMA (MEL) (CheckMate 067) [J].

Wolchok, Jedd D. ;

Chiarion-Sileni, Vanna ;

Gonzalez, Rene ;

Rutkowski, Piotr ;

Grob, Jean-Jacques ;

Cowey, C. Lance ;

Lao, Christopher D. ;

Schadendorf, Dirk ;

Ferrucci, Pier F. ;

Smylie, Michael ;

Dummer, Reinhard ;

Hill, Andrew ;

Haanen, John ;

Maio, Michele ;

McArthur, Grant ;

Walker, Dana ;

Jiang, Joel ;

Horak, Christine ;

Larkin, James ;

Hodi, Stephen .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 :127-128

[48] Efficacy and safety of nivolumab (NIVO) in patients with advanced melanoma (MEL) and poor prognostic factors who progressed on or after ipilimumab (IPI): Results from a phase II study (CheckMate 172). [J].

Schadendorf, Dirk ;

Ascierto, Paolo Antonio ;

Haanen, John B. A. G. ;

Espinosa, Enrique ;

Demidov, Lev V. ;

Garbe, Claus ;

Lorigan, Paul ;

Gogas, Helen ;

Hoeller, Christoph ;

Guren, Tormod Kyrre ;

Rorive, Andree ;

Rutkowski, Piotr ;

Munoz-Couselo, Eva ;

Dummer, Reinhard ;

Carneiro, Ana ;

Hospers, Geke ;

Grigoryeva, Elena Borisovna ;

Bhore, Rafia ;

Nathan, Paul .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[49] Adjuvant nivolumab (NIVO) plus ipilimumab (IPI) for resected high-risk stages IIIC/IV melanoma (MEL). [J].

Khushalani, Nikhil I. ;

Kim, Youngchul ;

Gibney, Geoffrey Thomas ;

Kudchadkar, Ragini Reiney ;

Eroglu, Zeynep ;

Markowitz, Joseph ;

Czupryn, Maria P. ;

Thebeau, Melissa S. ;

McCormick, Lori ;

Richards, Allison ;

Weber, Jeffrey S. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[50] Regional differences in overall survival (OS) in patients with advanced melanoma (MEL) who received nivolumab (NIVO) combined with ipilimumab (IPI) or NIVO alone in a phase 3 trial (CheckMate 067) [J].

Grob, J-J. ;

Schadendorf, D. ;

Wagstaff, J. ;

Marquez-Rodas, I. ;

Lebbe, C. ;

Ascierto, P. A. ;

Hodi, F. S. ;

Grossmann, K. ;

Hassel, J. C. ;

Walker, D. ;

Bhore, R. ;

Larkin, J. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2017, 28

← 1 2 3 4 5 →